Submitted by Anonymous (not verified) on 5 April 2024 - 15:04
Opinion/decision on a Paediatric investigation plan (PIP): Recarbrio, relebactam (MK-7655A),cilastatin sodium,imipenem monohydrate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0090/2023
Source: